HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice.

Abstract
We have reported that interleukin-1 beta (IL-1 beta) upregulates cardiac expression of vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2), raising the possibility that IL-1 beta plays an important role in VEGF-mediated neovascularization. In this study, we examined the cellular mechanism for ischemia-induced neovascularization using IL-1 beta knock-out (-/-) mice. Recovery of blood perfusion in ischemic hindlimb in IL-1 beta-/- mice was markedly (43% decrease) impaired as compared with the wild-type mice. CD31(+) vessel numbers and Ki-67(+) neo-capillaries were significantly (P < 0.01) decreased 44% and 68%, respectively. IL-1 beta expression was localized in the capillary vessels in ischemic limb muscles. Ischemia-induced expressions of hypoxia-inducible factor 1 alpha (HIF-1 alpha), VEGF, its receptor VEGFR-2 and vascular cell adhesion molecule-1 (VCAM-1) were markedly inhibited in the IL-1 beta-/- mice. Hindlimb ischemia-induced an increase (1.22% out of total nuclear cell) in CD34(-)/B220(-)/CD3(-)/Flk-1(+) hematopoietic stem cell population in peripheral blood in the wild-type mice, whereas in the IL-1 beta-/- mice such increase was only 0.09%. Injection of IL-1 beta protein into the wild-type mice markedly increased the ratio of the CD34(-)/B220(-)/CD3(-)/Flk-1(+) cell population (from 0.03% to 0.7%) in the peripheral blood associated with an increase in the number of endothelial cells. Such IL-1 beta-mediated increases in cell numbers were blocked by co-injection of anti-VEGF antibody. CD34(-)/B220(-)CD3(-)Flk-1(+) cells trans-differentiated into eNOS- and CD31-expressing endothelial cells in vivo and in vitro. This study demonstrates that IL-1 beta plays a key role in ischemia-induced neovascularization by mobilizing CD34(-)/B220(-)CD3(-)Flk-1(+) endothelial precursor cells in a VEGF-dependent manner as well as by upregulating expressions of VEGF, VEGFR-2 and adhesion molecules on endothelial cells.
AuthorsKatsuya Amano, Mitsuhiko Okigaki, Yasushi Adachi, Soichiro Fujiyama, Yasukio Mori, Atsushi Kosaki, Toshiji Iwasaka, Hiroaki Matsubara
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 36 Issue 4 Pg. 469-80 (Apr 2004) ISSN: 0022-2828 [Print] England
PMID15081307 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD34
  • CD3 Complex
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Interleukin-1
  • Ki-67 Antigen
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Transcription Factors
  • Vascular Cell Adhesion Molecule-1
  • Vascular Endothelial Growth Factor A
  • RNA
  • Vascular Endothelial Growth Factor Receptor-2
  • Leukocyte Common Antigens
Topics
  • Animals
  • Antigens, CD34 (biosynthesis)
  • Blotting, Western
  • CD3 Complex (biosynthesis)
  • Calibration
  • Cell Differentiation
  • Cell Separation
  • Endothelium, Vascular (metabolism)
  • Flow Cytometry
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Immunohistochemistry
  • Interleukin-1 (genetics, metabolism, physiology)
  • Ischemia
  • Ki-67 Antigen (biosynthesis)
  • Laser-Doppler Flowmetry
  • Leukocyte Common Antigens (biosynthesis)
  • Male
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Neovascularization, Pathologic
  • Perfusion
  • Platelet Endothelial Cell Adhesion Molecule-1 (biosynthesis)
  • RNA (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Transcription Factors (metabolism)
  • Up-Regulation
  • Vascular Cell Adhesion Molecule-1 (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)
  • Vascular Endothelial Growth Factor Receptor-2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: